Learn About the All of Us Research Program

The National Institutes of Health’s All of Us Research Program is an effort to gather health data from one million or more people living in the United States. This data from diverse population groups will be stored in a database that researchers can use to learn how people’s genetic makeup, habits and activities, and environment affect their health — which may help researchers find new ways to treat and prevent disease.

Participants in All of Us can choose to get DNA test results over time. DNA testing can give people information about their ancestry, their genetic traits, and their risk of developing certain health conditions.

In this course, health care providers will learn about the All of Us Research Program, the types of DNA test results available to participants, and resources participants can access through the program, like genetic counseling.

After completing the course, providers will be able to answer questions about the research program and guide participants in using what they learn through All of Us to inform health care decisions.

Once you complete this course, we encourage you to enroll in Learn About Genetic Testing and Counseling. 

About the QuizToo Platform

QuizToo provides health care providers a new and easy way to learn and earn continuing education (CE) credits. As a health care provider, you will receive questions on the days and times you choose. You can also choose to get the questions by text or email. If you answer a question wrong, you get additional educational information on the topic before trying to answer the question again. If you miss answering a question on the day it is sent to you, you can answer it the next time you login to QuizToo. Once all 20 questions have been attempted, you will receive your continuing education credits.

Disclosure Statements:

Course Developers:

Ana Forsythe, MS; Andrea Mongler, MPH; Amy Morrow, Ph.D.; Melanie Schwarz, MA; Linda Squiers, Ph.D.; and Toufeeq Syed, Ph.D., MS, have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Alexa Ortiz, MSN, RN, has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• VGHCX (Vanguard Health Care Fund Investor) Shares—Stocks owned by Spouse—Relationship Has Not Ended

Holly Peay, Ph.D., has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Janssen Pharmaceuticals—Contracted Research—Relationship Has Not Ended
• Sarepta Therapeutics—Contracted Research—Relationship Has Not Ended
• Travere Therapeutics—Contracted Research—Relationship Has Not Ended
• Orchard Therapeutics—Contracted Research—Relationship Has Not Ended
• Merck—Contracted Research—Relationship Has Not Ended

Any financial relationship that was found to be relevant has been mitigated.

Planners and other Administrative Support:

Amy Morrow, Ph.D.; Toufeeq Syed, Ph.D., MS; Linda Squiers, Ph.D.; Andrea Mongler, MPH; Melanie Schwarz, MA; and Ana Forsythe, MS, have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Alexa Ortiz, MSN, RN, has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• VGHCX (Vanguard Health Care Fund Investor) Shares—Stocks owned by Spouse—Relationship Has Not Ended

Holly Peay, Ph.D., has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Janssen Pharmaceuticals—Contracted Research—Relationship Has Not Ended
• Sarepta Therapeutics—Contracted Research—Relationship Has Not Ended
• Travere Therapeutics—Contracted Research—Relationship Has Not Ended
• Orchard Therapeutics—Contracted Research—Relationship Has Not Ended
• Merck—Contracted Research—Relationship Has Not Ended

Any financial relationship that was found to be relevant has been mitigated.

Commercial Support

This activity is not commercially supported.

Course Credits

Total Credits: 1

Upon completion of this course, you will receive a completion message with instructions to submit a course evaluation. After you have completed the evaluation, you will receive a certificate of completion to obtain your 1 credit/hour.

• McGovern Medical School at the University of Texas Health Science Center at Houston designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• McGovern Medical School at the University of Texas Health Science Center at Houston designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
• Cizik School of Nursing at UTHealth is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 1.0 contact hours of Nursing Professional Development

Accreditation Statement

McGovern Medical School at the University of Texas Health Science Center at Houston is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.